Skip to content

ASPIRE (Aub-haS2 Plus bIomaRkErs)

Validation of the AUB-HAS2 Score in a Brazilian Population and Study of the Additional Impact of Biomarkers in Predicting Perioperative Risk

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05742282
Acronym
ASPIRE
Enrollment
2500
Registered
2023-02-23
Start date
2025-06-21
Completion date
2026-10-30
Last updated
2025-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative Medicine

Brief summary

ASPIRE is a prospective, multicenter, observational study that will assess the performance of AUB-HAS2 to predict the occurrence of major adverse cardiovascular events 30-days after a non-cardiac surgery and the additional role of high-sensitivity troponin T and NT-ProBNP biomarkers in the accuracy of different event prediction indexes after non-cardiac procedures.

Detailed description

Primary objectives: Primary objective of the validation arm: to analyze the accuracy of the AUB-HAS2 index in predicting the occurrence of myocardial infarction, stroke and death within 30 days after non-cardiac surgeries. Primary objective biomarker arm: to analyze the additional role of high-sensitivity troponin T and NT-ProBNP biomarkers in the accuracy of different event prediction indexes after non-cardiac surgeries. Secondary objectives: To analyze the potentially preventable factors related to adverse outcomes after non-cardiac surgeries in order to offer subsidies for more assertive guidelines regarding the implementation of perioperative protection strategies. Compare the performance of these scores with others that have already been validated (ACP and Lee - see Annex A).

Interventions

None listed

Sponsors

Hospital Samaritano Paulista
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 40 years, in the preoperative period of non-cardiac procedures, with expected hospitalization for at least 24 hours postoperatively.

Exclusion criteria

* Refusal to sign the informed consent form.

Design outcomes

Primary

MeasureTime frameDescription
RATE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS30 daysCOMPOSITE OF DEATH, MYOCARDIAL INFARCTION AND STROKE

Secondary

MeasureTime frame
RATE OF MYOCARDIAL INJURY30 days

Countries

Brazil

Contacts

Primary ContactPEDRO DE BARROS E SILVA, MD PhD
centrodeestudos@samaritanopaulista.com.br551128275000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026